HLA class II genes modulate vaccine-induced antibody responses to affect HIV-1 acquisition
Abstract
HLA class II modulated the quantity, quality, and efficacy of antibody responses in the RV144 HIV vaccine trial.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Jul 15, 2015
- Source ID
- 10.1126/scitranslmed.aab4005
Entities
People
- Allan C deCamp
- Daniel E. Geraghty
- David C. Montefiori
- Georgia D. Tomaras
- Guido Ferrari
- Gustavo H. Kijak
- Heather A. Prentice
- Jaranit Kaewkungwal
- Jerome H Kim
- Julie McElrath
- Merlin L Robb
- Morgane Rolland
- Nelson Michael
- Nicole L. Yates
- Peter B Gilbert
- Philip K. Ehrenberg
- Punnee Pitisuttithum
- Rasmi Thomas
- Richard A. Koup
- Richard Apps
- Robert J. O'connell
- Robert T. Bailer
- Shelly J. Krebs
- Sorachai Nitayaphan
- Supachai Rerks-ngarm
- Susan Zolla-Pazner
- Wyatt Nelson
- Xiaoying Shen
- Youyi Fong
Organizations
- Duke University
- Fred Hutchinson Cancer Center
- Gates Foundation
- Grossman School of Medicine
- Henry M. Jackson Foundation for the Advancement of Military Medicine
- Mahidol University
- Ministry of Public Health
- National Institute of Allergy and Infectious Diseases
- National Institutes of Health
- United States Department of Defense
- United States Military HIV Research Program